Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective, Observational Study Using a Healthcare Database to Assess the Pregnancy Outcome in Women Exposed to Dayvigo® During Pregnancy Compared to an Unexposed Control Population

NCT06744673 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT06744673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06744673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective, Observational Study Using a Healthcare Database to Assess the Pregnancy Outcome in Women Exposed to Dayvigo® During Pregnancy Compared to an Unexposed Control Population
Lead sponsor
Eisai Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
January 3, 2025
Completion date
December 30, 2025
Enrollment
861 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy, sleep initiation and maintenance disorders